Biotech firms like Amgen Inc. (AMGN) and Regeneron Pharmaceuticals, Inc. (REGN) are pushing the boundaries of medicine - ...

It also featured insights on climate change’s impact on chest medicine and data on a promising asthma treatment. Watch the ...

Does an asthma diagnosis mean living with it your entire life or can asthma be cured? Keep reading for the answer as well as ...

Asthma management in winter can be a challenge, but with the right tools, your symptoms will be better controlled. By getting ...

Upstream Bio, which raised $293 million in an initial public offering in October, has hired veteran corporate attorney ...

Health Canada has approved Omlyclo, the first omalizumab biosimilar in Canada, for the treatment of chronic idiopathic ...

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of December ...

FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older ...

Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from ...

Delinking PBM service fees from drug prices and sharing rebate savings with patients, represent critical steps toward fixing ...

A study shows that of the one in eight children in several African countries who have asthma, the vast majority are undiagnosed and therefore untreated.

ALK (ALKB:DC / OMX: ALK B) today announced that its European regulatory filing for ACARIZAX® (house dust mite sublingual allergy immunotherapy ...